Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Operating Expenses (2016 - 2025)

OptimizeRx (OPRX) has disclosed Operating Expenses for 16 consecutive years, with $15.5 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 15.54% to $15.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.9 million through Dec 2025, down 15.3% year-over-year, with the annual reading at $61.9 million for FY2025, 15.3% down from the prior year.
  • Operating Expenses hit $15.5 million in Q4 2025 for OptimizeRx, roughly flat from $15.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $28.7 million in Q4 2023 to a low of $6.8 million in Q1 2021.
  • Historically, Operating Expenses has averaged $14.5 million across 5 years, with a median of $13.9 million in 2023.
  • Biggest five-year swings in Operating Expenses: surged 115.82% in 2023 and later crashed 36.03% in 2024.
  • Year by year, Operating Expenses stood at $11.8 million in 2021, then increased by 13.15% to $13.3 million in 2022, then skyrocketed by 115.82% to $28.7 million in 2023, then plummeted by 36.03% to $18.4 million in 2024, then decreased by 15.54% to $15.5 million in 2025.
  • Business Quant data shows Operating Expenses for OPRX at $15.5 million in Q4 2025, $15.5 million in Q3 2025, and $15.4 million in Q2 2025.